Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
—1,195.191,204.711,221.691,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
—638.56640.21645.32638.69——
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
—831.57840.48844.16834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
—213.36213.36215.79212.77——
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
—1,449.261,454.771,462.651,447.95——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
—2,382.452,371.192,380.452,362.86——
PGEN:NASDAQ
Precigen Inc
$4.02
+1.52%
(+0.060) 1D
$4.14
+2.99% (+0.12)
Pre-market
Closed: Apr 28, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PGEN...
Open
$3.96
High
$4.10
Low
$3.93
Mkt. cap
1.42B
Avg. vol.
4.77M
Volume
407.00
52-wk high
$5.46
52-wk low
$1.22
EPS
-$1.37
Beta
1.12
Shares outstanding
353.93M
No. of employees
160
News stories
From sources across the web
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
FoundedMay 21, 1998
Headquarters-
SectorBiotechnology
Websiteprecigen.com
Last report
Mar 25, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-0.01/ (-0.04 est.)USD
+75.00%beat
Revenue / Estimate
4.56M/ (8.29M est.)USD
-44.90%miss
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.34M
856.00K
2.92M
4.56M
Cost of goods sold
1.10M
1.56M
13.41M
8.59M
Cost of revenue
1.10M
1.56M
13.41M
8.59M
Research and development expenses
10.48M
11.02M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.36M
16.13M
23.99M
17.64M
Operating expense
22.84M
27.16M
23.99M
17.64M
Total operating expenses
23.94M
28.71M
37.40M
26.23M
Operating income
-22.60M
-27.86M
-34.48M
-21.67M
Other non operating income
-32.47M
4.43M
-111.50M
60.00K
EBT including unusual items
-54.15M
-26.64M
-146.34M
-23.50M
EBT excluding unusual items
-54.15M
-22.73M
-146.34M
-23.50M
Income tax expense
-
3.00K
-
-
Effective tax rate
-
-0.01%
-
-
Other operating expenses
-
-
-
-
Net income
-54.15M
-26.64M
-146.34M
-23.50M
Net profit margin
-4,038.26%
-3,112.38%
-5,008.35%
-514.85%
Earnings per share
-0.18
-0.08
-
-
Interest and investment income
918.00K
696.00K
534.00K
1.07M
Interest expense
-1.00K
-
-902.00K
-2.96M
Net interest expenses
917.00K
696.00K
-368.00K
-1.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.97M
-27.23M
-33.68M
-20.53M
Gain or loss from assets sale
-
14.00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer